Clearstead Advisors, LLC X Biotech Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in X Biotech Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 17 shares of XBIT stock, worth $44. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17Holding current value
$44% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XBIT
# of Institutions
53Shares Held
4.45MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$2.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA945KShares$2.49 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny551KShares$1.45 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$652,9500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA221KShares$580,3850.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $80.1M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...